insights_auto
Hvorfor har GMAB gått ned? 2,42%?
Gå mer i dybdenchevron_right
GMAB:CPH
Genmab
2 257,00 DKK
arrow_downward
−2,42%(−56,00) 1 D
2. okt., 17:00:00 GMT+2 · DKK
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for GMAB …
Åpne
2 274,00 DKK
Høy
2 314,00 DKK
Lav
2 235,00 DKK
Markedsverdi
145,45 mrd.
Snittvolum
112,20k
Volum
106,71k
52 u høy
2 369,00 DKK
52 u lav
1 512,00 DKK
Utestående aksjer
62,41 mill.
Antall ansatte
3k
Åpne
2 274,00 DKK
Høy
2 314,00 DKK
Lav
2 235,00 DKK
Markedsverdi
145,45 mrd.
Snittvolum
112,20k
Volum
106,71k
52 u høy
2 369,00 DKK
52 u lav
1 512,00 DKK
Utestående aksjer
62,41 mill.
Antall ansatte
3k
Nyhetssaker
Fra nettkilder og nyhetspartnere
TipRanks
·
for 1 time siden
Genmab Discloses Darwin Global as 5.11% Major Shareholder
Yahoo! Finance Canada
·
for 2 timer siden
Major Shareholder Announcement
AD HOC NEWS
·
for 6 timer siden
Genmab outlines three Phase 3 readouts and Genmab stock costs EUR 306.70
TradingView
·
for 6 timer siden
Genmab A/S Stock 12‑Month Price Target Raised to $39.56, Implies 14% Upside
Profil
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
Om Genmab
Administrerende direktørJan G. J. van de Winkel
Ansatte3,12k
Grunnlagt11. juni 1998
Hovedkontor-
Sektor-
Nettstedgenmab.com